ICVS

ICVS

ICVS collaborates in first study on the prevalence of asthma in Portugal: more than 570 thousand people have the disease

More than 570,000 adults live with asthma in Portugal, a disease that has a prevalence of 7.1%. Of these thousands of people, almost seven in 10 (68%) do not have their disease under control, show data from “EPI-ASTHMA - Prevalence and characterization of people with asthma, according to the severity of the disease, in Portugal”, a study developed in collaboration by ICVS, CINTESIS of the University of Porto and AstraZeneca Portugal.

ICVS Researcher Vitória Baptista awarded two grants

Vitória Baptista, a PhD student in Biomedical Engineering at the Centre of Microelectromechanical Systems (CMEMS) and the Life and Health Sciences Research Institute (ICVS) at the University of Minho, has been awarded an “EMBO Scientific Exchange Grant” and a “FEMS Research and Training Grant".

Compound that aids in the digestion of fatty foods within the intestine demonstrates potential as a treatment for a rare brain disorder

In a work, recently published in the Journal of Clinical Investigation, researchers at the Life and Health Science Research Institute (ICVS) at the University of Minho, in Portugal, used animal models of spinocerebellar ataxia type 3 or Machado-Joseph disease (SCA3/MJD) to test a promising drug: the compound tauroursodeoxycholic acid (TUDCA for short).